XTL Biopharmaceuticals Ltd ADR (XTLB) — Working Capital to Net Assets Ratio
XTL Biopharmaceuticals Ltd ADR (XTLB) has a Working Capital to Net Assets ratio of -16.0% as of March 2025. Working capital of $-867.00K (current assets of $1.34 Million minus current liabilities of $2.21 Million) is measured against net assets of $5.43 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See XTL Biopharmaceuticals Ltd ADR (XTLB) balance sheet quality index to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
XTL Biopharmaceuticals Ltd ADR Working Capital to Net Assets (2003–2024)
This chart shows how XTL Biopharmaceuticals Ltd ADR's Working Capital to Net Assets ratio has evolved across 22 annual periods from 2003 to 2024. As of March 2025, the ratio stands at -16.0%, reflecting working capital of $-867.00K against net assets of $5.43 Million USD. Check how tangible is XTL Biopharmaceuticals Ltd ADR's equity to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for XTL Biopharmaceuticals Ltd ADR (2003–2024)
The table below presents the year-by-year Working Capital to Net Assets ratio for XTL Biopharmaceuticals Ltd ADR from 2003 to 2024, covering 22 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see XTL Biopharmaceuticals Ltd ADR market capitalisation.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2024 | -16.0% | $-867.00K | $5.43 Million | $1.34 Million | $2.21 Million | ▼ -98.8 pp |
| 2023 | 82.9% | $1.84 Million | $2.22 Million | $2.05 Million | $206.00K | ▼ -7.6 pp |
| 2022 | 90.5% | $3.62 Million | $4.00 Million | $3.81 Million | $187.00K | ▼ -22.1 pp |
| 2021 | 112.6% | $6.01 Million | $5.33 Million | $6.24 Million | $231.00K | ▲ +18.7 pp |
| 2020 | 93.9% | $5.87 Million | $6.25 Million | $6.12 Million | $254.00K | ▼ -0.6 pp |
| 2019 | 94.5% | $6.60 Million | $6.98 Million | $6.83 Million | $232.00K | ▼ -0.9 pp |
| 2018 | 95.4% | $7.94 Million | $8.32 Million | $8.20 Million | $253.00K | ▼ -67.8 pp |
| 2017 | 163.2% | $5.91 Million | $3.62 Million | $6.21 Million | $300.00K | ▲ +73.0 pp |
| 2016 | 90.2% | $2.42 Million | $2.69 Million | $2.75 Million | $330.00K | ▲ +11.9 pp |
| 2015 | 78.4% | $3.83 Million | $4.89 Million | $4.26 Million | $436.00K | ▲ +32.3 pp |
| 2014 | 46.1% | $2.16 Million | $4.68 Million | $3.12 Million | $965.00K | ▼ -10.9 pp |
| 2013 | 57.0% | $3.87 Million | $6.79 Million | $5.09 Million | $1.22 Million | ▲ +34.3 pp |
| 2012 | 22.7% | $2.14 Million | $9.42 Million | $3.79 Million | $1.65 Million | ▼ -5.0 pp |
| 2011 | 27.7% | $955.00K | $3.44 Million | $1.58 Million | $629.00K | ▲ +18.6 pp |
| 2010 | 9.1% | $259.00K | $2.83 Million | $1.22 Million | $963.00K | ▲ +2166.3 pp |
| 2009 | -2157.1% | $-151.00K | $7.00K | $557.00K | $708.00K | ▼ -2254.3 pp |
| 2008 | 97.1% | $1.39 Million | $1.43 Million | $3.39 Million | $2.00 Million | ▼ -2.5 pp |
| 2007 | 99.6% | $8.53 Million | $8.56 Million | $13.90 Million | $5.37 Million | ▼ -0.1 pp |
| 2006 | 99.7% | $22.69 Million | $22.76 Million | $26.10 Million | $3.40 Million | ▼ -1.5 pp |
| 2005 | 101.2% | $11.38 Million | $11.25 Million | $13.79 Million | $2.41 Million | ▼ -2.1 pp |
| 2004 | 103.3% | $20.24 Million | $19.60 Million | $23.77 Million | $3.53 Million | ▲ +6.4 pp |
| 2003 | 96.9% | $19.97 Million | $20.61 Million | $22.97 Million | $3.00 Million | — |